Details for 2018190333

Up to date per 01.04.2026

Actions

Title / Product Name

VERFAHREN ZUR HERSTELLUNG VON OXAZOLO[4,5-B]PYRIDIN- UND THIAZOLO[4,5-B]PYRIDIN-DERIVATEN ALS IRAK4-INHIBITOREN ZUR BEHANDLUNG VON KREBS

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2018190333

EP Publication Number

3466955

E-Number

1345485

Language

PCT Number

Publication Date

10.04.2019 A

16.12.2020 B1

Registration Date

16.12.2020

AT Publication Date

15.01.2021

Application Date

12.01.2015

Registration Number

Priorities

13.01.2014

158CH2014

20.06.2014

3000CH2014

IPC

C07D 498/04 20060101AFI20200617BHEP

Maximum Duration of Protection

12.01.2035

Owner

Aurigene Oncology Limited39-40 KIADB Industrial Area Electronic City Phase-II Hosur Road Bangalore 560100IN

Representative

Babeluk Patentanwälte GmbHFlorianigasse 26/31080 WienAT

Inventor

GUMMADI, Venkateshwar, RaoBalaji Nilayam 62 1st main Veerabhadraswamylayout Doddanagamangala Electronic City Bangalore 560100IN

SAMAJDAR, SusantaFlat R801 H. M Tambourine Jaraganahalli J.P. Nagar 6th Phase Bangalore 560078IN

Information about Fees